edg-500
edgewise therapeutics
['hypertrophic cardiomyopathy', 'cardiomyopathy', 'cardio', 'edgewise therap']
we presented over the weekend on edg-7500, a novel investigational therapy for the treatment of #hypertrophic cardiomyopathy with a differentiated mechanism of action at acc.23/wcc. check out our scientific poster here: 
Edgewise is a biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe muscle disorders.